Paciuli Posted - 2 days ago

$OSS

misterdavid Posted - 2 days ago

$SOUN $OSS

Fish_on Posted - 4 days ago

$NLST Nothing surprising for the majority of longs who have been waiting for some payback. News pointing out the evil that innovators suffer from will help put a spot light on that tick and kill it (I believe) Chuck has been in the forefront of calling bullshit. I applaud nearly everything he has done since I've known/owned NLST. Only thing I could ask for is to provide shareholders more news regarding partnerships and other innovators that have enjoyed NLST tech along the way. I am confident that our US military has NLST inside... refer to $OSS for factual NLST tech use. Beyond what OSS has previously shared, other systems that involve memory are not and will not be available for security reasons. Have a peaceful rest of your weekend NLST fans. Cheers - https://innovationgadfly.com/new-compelling-evidence-of-anti-innovation-bias/?utm_source=newsletter&utm_medium=email&utm_term=2024-11-16&utm_campaign=New+Compelling+Evidence+of+Anti-Innovation+Bias

misterdavid Posted - 6 days ago

$IONQ $SOUN $OSS

misterdavid Posted - 6 days ago

$SOUN $OSS

NOFAPGOD Posted - 6 days ago

$OSS my new favorite stock, ill start a position here in a few weeks.

Stockmcdavid Posted - 1 week ago

$OSS free money

dcme010711 Posted - 1 week ago

$OSS no brainer buy here, this will double by next year for sure, maybe as soon as end of Q1 2025 when they materialize soe big defense contracts. Long holder here

Stockmcdavid Posted - 1 week ago

$OSS in

TheAceofTrades68 Posted - 1 week ago

$OSS

dcme010711 Posted - 1 week ago

$OSS I've been a long OSS buyer and holder, what thoughts here on direction? Slow and steady climb? I'm going to hold regardless just wanted some thoughts. Thanks!

spdandpwr Posted - 2 weeks ago

$FLUX Everything is ripping except $OSS and FLUX lol

Patticus Posted - 1 month ago

$OSS

Ohnaw_ohchea Posted - 1 month ago

$OSS this stick just has my heart ❤️

Jnnnk Posted - 1 month ago

$OSS there seems to be some optimism building ahead of ER. Fair warning, this one has disappointed quarter after quarter for years. I don’t think it eill be any different this time.

SmartContent Posted - 1 month ago

$INMB Strong upside as Alzheimer’s and cancer therapies show promise with buy ratings from analysts. $UGRO Expanding into new sectors with major contracts, including P.F. Chang’s and municipal projects. $LFMD Telehealth and weight management programs continue to drive growth with high demand for GLP-1 treatments. $GNSS Securing critical emergency communication contracts, bolstering leadership in public safety technology. $OSS Strengthening defense contracts with rugged AI computing solutions for military applications. MODD FDA-approved insulin pump MODD1 is well-positioned to capture growing diabetes market share. STTK Insider buying signals confidence as the company shifts focus to autoimmune therapies post-restructuring. LFCR Scaling contract development with multimillion-dollar deals and expanded production capacity.

StockBoyAri Posted - 1 month ago

$OSS moving. Lets see $3+

SmartContent Posted - 1 month ago

$OSS The defense sector has reliable, long-term demand, and their contracts with the U.S. Special Operations Command for rugged AI solutions place them in a stable, high-growth area. Government contracts provide a strong revenue base, and AI has increasing applicability across sectors. $MODD FDA clearance for the MODD1 insulin pump is a significant milestone, and the personalized metabolic therapy space is growing. Early movers in FDA-approved medical devices can see strong returns as they penetrate the market. $GNSS global contracts for emergency response systems offer consistent growth and strong demand in niche markets. Their contract security and international reach make them a good balance of growth and stability. $LNSR leads in ophthalmic devices, especially with over a million cataract procedures.

SmartContent Posted - 1 month ago

>$5 worth a look: $STTK Insider buying signals confidence, SL-325 autoimmune therapy. $UGRO Secured 12M in new cannabis contracts, positioning for strong growth with potential Florida market expansion​. $MODD FDA clearance of the MODD1 insulin pump sets the stage for growth in personalized metabolic therapy. $ASRV Maintains dividends and focuses on regional growth. $OSS Strengthened its defense sector presence with a contract from US S.O. Command for rugged AI solutions. PHX is benefiting from record royalty volumes and a significant dividend increase. GNSS continues to expand globally, securing critical contracts for its advanced emergency response systems. DALN is driving innovation with a new voter engagement tool for the 2024 election, enhancing digital reach. LNSR leads in ophthalmic devices, having surpassed one million cataract procedures with its cutting-edge laser systems. LFMD is expanding telehealth offerings, especially in weight management, with rising demand for GLP-1 therapies.

Mattvv Posted - 1 month ago

$OSS $NVDA small undiscovered AI play in OSS

kshonstocks Posted - 1 month ago

taking the $OSS, like the 200 dma b/o

DipBuyInvester Posted - 1 month ago

$OSS TANH making us happy!! Added more!!

kshonstocks Posted - 1 month ago

$OSS hitting scan one to eye going forward imo

Investorwait Posted - 1 month ago

@Bionical Those DCF models do not take into account that $OSS revenue should increase 50% per year if they execute according to their $1+ billion multi-year sales backlog plan. Then even these projections are too pessimistic: fintel.io/sfo/us/oss

Bionical Posted - 1 month ago

@Investorwait @anesthesia_sleep $OSS is overvalued on all accounts of its intrinsic value … lol

Investorwait Posted - 1 month ago

@anesthesia_sleep You may compare this with $OSS who is in the same business. I believe One Stop System is better positioned for massive recession-proof growth in the upcoming 18 months.

Hardballer Posted - 09/30/24

$OSS

Investorwait Posted - 09/25/24

I believe the latest news from Sep 12 could be the game changer for $OSS with its tiny marketcap, reflecting no substantial growth. "OSS Enters into a Cooperative Research and Development Agreement with the U.S. Special Operations Command ... reflects our multi-year strategy focused on expanding our offerings and establishing relationships across all branches of the U.S. Armed Forces. The SOF CRADA represents an important pillar within our $1+ billion sales pipeline, as we believe the U.S. Department of Defense will accelerate the adaptation of the types of enterprise class architecture OSS provides for AI/ML, sensor fusion and autonomy applications." https://onestopsystems.com/pages/press-release-viewer?i=137835 "The United States Special Operations Command is the unified combatant command charged with overseeing the various special operations component commands of the Army, Marine Corps, Navy, and Air Force of the United States Armed Forces." https://en.wikipedia.org/wiki/United_States_Special_Operations_Command

intratio Posted - 09/25/24

https://www.intratio.com/stock-forecast/OSS ONE STOP SYSTEMS, INC. The trained A.I is predicting that the stock price of this company has an unfavorable short-term setup with a very negative long-term outlook $OSS

Investorwait Posted - 09/24/24

$OSS Has everybody understood the significance of the last press release? "One Stop Systems (OSS) has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Special Operations Command. ... The SOF CRADA is part of OSS's $1+ billion sales pipeline, reflecting the company's focus on enterprise-class architecture for AI/ML, sensor fusion, and autonomy applications in defense." Sales are currently 50 million as is the market cap. https://onestopsystems.com/pages/press-release-viewer?i=137835 https://en.wikipedia.org/wiki/United_States_special_operations_forces